Think shock absorbers for the human body. Moximed could help active and young patients who have osteoarthritis prolong the amount of time before total knee replacement. The Heyward, Calif.-based company’s Kinespring Knee Implant System is a medical device that absorbs part of the load put on the knee, without changing anatomy. The device is positioned […]
(Reuters) - Johnson & Johnson is negotiating a potential $2 billion settlement with patients who received its recalled artificial hip implant, Bloomberg News reported on Friday, citing five people familiar with the matter. J&J has offered to pa...
Johnson & Johnson’s (NYSE:JNJ) DePuy Synthes Spine is expanding its reach in the spine market with U.S. Food and Drug Administration clearance of three of its systems for use in adolescents with scoliosis undergoing posterior noncervical pedicle screw fixation. The Expedium, Viper and Viper 2 spine systems, which are already cleared for use in adults, […]
Biomet Inc. has made a $280 million binding offer to acquire the worldwide trauma business of Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics Inc. “This transaction will provide Biomet with a much stronger presence in the global trauma market and greatly expands our sports, extremities and trauma business, which is a meaningful growth driver for […]
DePuy Orthopaedics launched several new surgical products this week for knee, shoulder and hip revisions. The Johnson & Johnson (NYSE:JNJ) subsidiary accounted for $5.8 billion in sales in 2011, but those sales were offset by $521 million in costs associated with the 2010 recall of its metal-on-metal ASR hip replacement system. That line of products […]
Current medical news and unique business news for anyone who cares about healthcare. J&J company responds to FDA warning Johnson & Johnson’s (NYSE: JNJ) subsidiary DePuy Orthopaedics received a warning letter from U.S. regulators not to sell joint replacement products without proper approval. The Dec. 8 letter said a federal investigation at DePuy’s Warsaw, Indiana […]
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
Johnson & Johnson (NYSE:JNJ) could shell out up to $1 billion for lawsuits concerning its subsidiary DePuy Orthopaedics and the metal-on-metal hip implants that were found to shed minute metal particles into a patient’s bloodstream over time. Lawsuits over the ASR implant have piled up across the country, accusing DePuy of manufacturing a defective product, […]
Amid lawsuits concerning its Pinnacle metal-on-metal hip implant, Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics won U.S. Food & Drug Administration clearance for its next-generation Pinnacle ceramic-on-metal hip implant. Ceramic-on-metal is a novel combination in the hip implant market, having undergone two-year controlled, randomized, multicenter, non-inferiority clinical study and laboratory testing as part of the […]
DePuy Orthopaedics has a new man in the corner office, now that it’s named veteran Andrew Ekdahl president of the Johnson & Johnson (NYSE:JNJ) subsidiary. Ekdahl will replace David Floyd, who resigned in March amid a damaging recall of one of DePuy’s hip replacement lines that’s already cost the company nearly $1 billion in legal […]
Lawsuits over recalled hip implants made by Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopedics are being consolidated under a federal district court judge in Ohio. The multi-district litigation is slated to take place in the U.S. District Court for Northern Ohio under Judge David Katz, according to Montgomery, Alabama-based law firm Beasley Allen. One of the […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Major orthopedic implant makers like Johnson & Johnson's DePuy subsidiary are getting behind a project aimed at tracking hip and knee implants in 90 percent of U.S. hospitals, hoping to get ahead of the recall curve.
Less than a week after its recall of a pair of hip implants, DePuy Orthopaedics was hit with another series of lawsuits over the devices, this time alleging that the Johnson & Johnson (NYSE: JNJ) subsidiary knowingly sold defective products. Warsaw, Indiana-based DePuy pulled its ASR hip replacement system off the market last week after receiving reports that a higher-than-normal number of patients required surgeries to correct or remove defective implants.
DePuy Orthopaedics Inc., the Johnson & Johnson unit in Warsaw, Indiana, is voluntarily recalling its ASR hip replacement system after receiving reports that a higher-than-normal number of patients required surgeries to correct or remove defective implants.
Lawsuits over an allegedly faulty hip implant are piling up for DePuy Orthopaedics, with three more patients suing the Johnson & Johnson (NYSE:JNJ) subsidiary over its ASR acetabular cup. Cynthia Magowan, Harold Schoening and Katherin Balestra-Walter each received the device, according to a lawsuit filed in the California Superior Court for San Francisco, and each […]
Johnson & Johnson (NYSE:JNJ) provided investors and analysts with a glimpse into its medical device operation, which it called the world’s largest. Over the past two years, according to the presentation, the division posted $1.8 billion in operational sales growth (excluding special items such as acquisitions or legal expenses). The segment’s total sales during the […]
